Article Versions Notes

Bilal MS, Ejaz SA, Zargar S, Akhtar N, Wani TA, Riaz N, Aborode AT, Siddique F, Altwaijry N, Alkahtani HM, et al. Computational Investigation of 1, 3, 4 Oxadiazole Derivatives as Lead Inhibitors of VEGFR 2 in Comparison with EGFR: Density Functional Theory, Molecular Docking and Molecular Dynamics Simulation Studies. Biomolecules. 2022; 12(11):1612. https://doi.org/10.3390/biom12111612

Bilal, Muhammad Sajjad, Syeda Abida Ejaz, Seema Zargar, Naveed Akhtar, Tanveer A. Wani, Naheed Riaz, Adullahi Tunde Aborode, Farhan Siddique, Nojood Altwaijry, Hamad M. Alkahtani, and et al. 2022. "Computational Investigation of 1, 3, 4 Oxadiazole Derivatives as Lead Inhibitors of VEGFR 2 in Comparison with EGFR: Density Functional Theory, Molecular Docking and Molecular Dynamics Simulation Studies" Biomolecules 12, no. 11: 1612. https://doi.org/10.3390/biom12111612

Bilal, M. S., Ejaz, S. A., Zargar, S., Akhtar, N., Wani, T. A., Riaz, N., Aborode, A. T., Siddique, F., Altwaijry, N., Alkahtani, H. M., & Umar, H. I. (2022). Computational Investigation of 1, 3, 4 Oxadiazole Derivatives as Lead Inhibitors of VEGFR 2 in Comparison with EGFR: Density Functional Theory, Molecular Docking and Molecular Dynamics Simulation Studies. Biomolecules, 12(11), 1612. https://doi.org/10.3390/biom12111612